. Author manuscript; available in PMC: 2018 Oct 4.

Published in final edited form as: Int J Gynecol Pathol. 2017 May;36(3):240–252. doi: 10.1097/PGP.0000000000000325

TABLE 5.

Univariate subanalysis (early stage: Stage I)

Parameter	Variable	n (%)		P
Parameter	Variable	Nonrecurrent (n = 79)^*	Recurrent (n = 6)	P
Treatment	Surgery only	62 (95.3)	1 (16.7)	0.0001
	Surgery+chemo	3 (4.6)	5 (83.3)
Mitotic rate	<4/HPF	55 (69.6)	3 (50.0)	0.377
	≥4/HPF	24 (30.4)	3 (50.0)
CD56	Neg+low: ≤80%	44 (61.1)	0 (0.0)	0.012
	High: >80%	28 (38.9)	5 (100.0)
SMAD3	Neg+low: ≤80%	62 (89.9)	1 (20.0)	0.001
	High: >80%	7 (10.1)	4 (80.0)
CD56 and SMAD3	Low-low	22 (78.6)	1 (20.0)	0.007
	Low-high	2 (7.1)	0 (0.0)
	High-high	4 (14.3)	4 (80.0)

Data is missing in some cases.

Bold values are statistically significant.